Open AccessEffects of empagliflosin on the course of non-alcoholic fatty liver disease in experiment
Author(s) -
A. V. Bunyat,
Д. С. Суханов
Publication year - 2021
Publication title -
biomedicina
Language(s) - English
Resource type - Journals
eISSN - 2713-0428
pISSN - 2074-5982
DOI - 10.33647/2713-0428-17-3e-144-146
Subject(s) - fatty liver , alcoholic liver disease , empagliflozin , disease , medicine , gastroenterology , alcoholic fatty liver , endocrinology , diabetes mellitus , type 2 diabetes , cirrhosis
Effects of the SGLT-2 drug of the group of empagliflozin inhibitors on the biochemical and histological picture of non-alcoholic fatty liver disease in mice was evaluated.